AHA Center for Health Innovation
As hospitals and health system executives refine strategies to improve recruitment and retention of nurses, particularly nurse leaders, nonsalary forms of compensation may need closer scrutiny. Most strategies tend to focus on role, scope, span of control, empowerment, recognition and professional…
A new AHA Leadership Scan episode will explore how some hospitals and health systems have developed more resilient and proactive approaches to identifying, vetting and purchasing sustainable products.
Walgreens last week entered into a strategic partnership with Pearl Health, a technology platform for primary care physicians in value-based care arrangements. Just days earlier, Bloomberg reported that Walmart was exploring the purchase of a majority stake in ChenMed, a value-based care…
Our panel of physicians and nursing experts share their experience to help you understand and achieve real-life utilization of: 1) decreased variation, 2) standard communication and simulation, and 3) front-line participation in quality improvement, and 4) organizational framework for quality…
A newly released report, “Primer for private-equity investing for health care organizations,” from Concord Health Partners and the AHA Center for Health Innovation explores what leaders need to know about private equity as they explore innovation investing.
The highly competitive post-pandemic labor market, particularly for specialists, is impacting the compensation packages health care providers are offering, experts say.
As hospitals and health systems continue to renew and strengthen the clinical workforce pipeline, they may want to take a closer look at how community colleges can help in this area.
A new study published this month in The Joint Commission Journal on Quality and Patient Safety finds that virtual MDRs combined with other interventions led to more than 60% of discharges being below the mean LOS at Yuma Regional Medical Center in Arizona and delivered other benefits.
ChatGPT has problems with accuracy in making cancer treatment recommendations, according to a study recently published in JAMA Oncology. Researchers from Mass General Brigham found that one-third of GPT’s 3.5 recommendations went at least partially against 2021 National Comprehensive Cancer…
A new plan will transition Blue Shield of California’s drug supply management from CVS Health’s PBM to five companies — a move the payer believes will save its 4.8 million members as much as $500 million a year in drug costs or about 10% to 15% of what it spends on drugs annually.